Loxo Oncology Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil falls over 4% as investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
Loxo Oncology (LOXO) Prices 2.5M Common Follow-on at $26.50/Share
November 12, 2015 9:32 AM ESTLoxo Oncology (NASDAQ: LOXO) announced the pricing of its underwritten public offering of 2,500,000 shares of common stock at a public offering price of $26.50 per share. Gross proceeds to Loxo Oncology from this offering are expected to be approximately $66.3 million. Loxo Oncology intends... More
Loxo Oncology (LOXO) Commences 2M Share Common Stock Offering
November 10, 2015 4:01 PM ESTLoxo Oncology, Inc. (Nasdaq: LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced today that it has commenced an underwritten public offering of up to 2,000,000 shares of its common stock. Loxo Oncology also expects to grant the underwriters a 30-day option to purchase up to an additional 300,000 shares of its common stock offered in the public offering solely to cover overallotments, if any, at the public offering... More
